Scotland · NHS Scotland MSAN
NovoRapid FlexPen® (Insulin aspart) 100units/ml solution for injection 3ml pre-
MSAN(2022)5 · Level 3 · issued 04 Nov 2022
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. NovoRapid FlexPen® is out of stock until the week commencing 21st November 2022. | Out of stock | the week commencing 21st November 2022 |
| NovoRapid Penfill® (Insulin aspart) 100units/ml cartridges remain available and can support | Available | — |
| Trurapi Solostar® (Insulin aspart [biosimilar]) 100units/ml pens remain available and can | Available | — |
| NovoRapid FlexTouch® (Insulin aspart) 100units/ml pens remain available but cannot | Available | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2022:5
- Recorded
- 13 Aug 2026 22:03 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 13 Aug 2026 22:03 UTC
- Content hash
39a222512125ec8f3f157b914983f0e5eb70e20a93ee37a9a19b58128d21a49asha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2022-05.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.